O4‐08‐03: PSYCHOSOCIAL OUTCOMES OF APOE E4 GENOTYPE DISCLOSURE IN THE GENERATION STUDY

O4-08-03 PSYCHOSOCIAL OUTCOMES OF APOE E4 GENOTYPE DISCLOSURE IN THE GENERATION STUDY Angela R. Bradbury, Jason Karlawish, J Scott Roberts, Brian L. Egleston, Linda Patrick-Miller, Elisabeth McCarty Wood, Scott YH. Kim, Jan Jaeger, Neeraja Reddy, Cara Cacioppo, Dare Henry-Moss, Stephanie Jideama, Demetrios Ofidis, Fonda Liu, Angelika Caputo, Marie-Emmanuelle Riviere, Mauritz Bezuidenhoudt, Carolyn Langlois, Eric M. Reiman, Pierre N. Tariot, Jessica B. Langbaum, University of Pennsylvania, Philadelphia, PA, USA; University of Michigan, Ann Arbor, MI, USA; Fox Chase Cancer Center, Philadelphia, PA, USA; Independent Consultant, Chicago, IL, USA; National Institutes of Health, Bethesda, MD, USA; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma, Basel, Switzerland; Banner Alzheimer’s Institute, Phoenix, AZ, USA; Arizona Alzheimer’s Consortium, Phoenix, AZ, USA. Contact e-mail: angela.bradbury@uphs.upenn.edu